Avella Newsroom

HOUSTON, Feb. 23, 2017 - Advanced Pharma, Inc. d/b/a Avella of Houston is conducting a voluntary recall of all unexpired sterile injectable products labeled "latex free" that were produced at Advanced Pharma, Inc.'s Houston location between September 1, 2016 and February 16, 2017 to the user level (hospitals and institutions) because such products may contain synthetic latex and/or natural latex.

Avella and Advanced Pharma have been unable to confirm with clarity whether its "latex free" label statements are accurate in all cases and are therefore conducting this recall in an abundance of caution.  The risk of potential adverse events related to a latex allergy, while rare, can range from local site reactions including swelling and inflammation to allergic reactions, which could be life-threatening to users who are sensitive to latex. These products were not distributed directly to patients or consumers, but rather to healthcare facilities (hospitals and institutions).

The organization has already received accreditation for its national specialty pharmacy and mail order programs

Avella Specialty Pharmacy has just announced that two of its pharmacies have received URAC accreditation in specialty pharmacy. URAC is a Washington, DC-based healthcare accrediting organization that establishes quality standards for the entire healthcare industry.

This location will allow one of the fastest-growing companies in the nation to better house its operations and plan for the future

Avella just announced that the company has transitioned into a new 50,000-square-foot corporate headquarters in Phoenix, Arizona. This move allows the company to conduct its clinical, operational and administrative processes under one roof while maintaining greater scalability for future growth.

Joel V. Brill, MD, FACP will contribute his expertise in managed care, advanced payment models and healthcare policy to the specialty pharmacy

Avella has announced that Joel V. Brill, MD, FACP will be serving as Medical Advisor for the organization. Dr. Brill brings more than 30 years of clinical and leadership experience to this leading specialty pharmacy, as well as specific expertise in value-based care, advanced payment models and leading-edge healthcare programs. 

The national specialty pharmacy is also the second fastest-growing privately-held company

Avella Specialty Pharmacy has announced that it is now the fourth largest privately-held company in the state, moving up from its previous ranking as the seventh, according to the Arizona Corporate Excellence (ACE) Awards. Avella was also recognized as the second fastest-growing company in Arizona.